Semaglutide significantly reduces risk of complications in patients with type 2 diabetes, study reveals
A pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic kidney disease. ...
May 24, 2024
0
2